SCHEMBL5161248

SCHEMBL5161248

CCN1C=CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL298741 0.84
Fluoride SCHEMBL29252244 0.82
Hydrochloric Acid SCHEMBL27848519 0.82
SCHEMBL17675426 0.81
SCHEMBL7275301 0.79
SCHEMBL28042239 0.78 CYP1A2 (0.30)
SCHEMBL371279 0.76 GNAI3 (0.33)
SCHEMBL7121806 0.75
SCHEMBL21427427 0.75
SCHEMBL249356 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020040581-A1 NOVEL QUINOLINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT 고려대학교 산학협력단 2020-02-27 WO claimed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
US-20230365549-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2023-11-16 US disclosed
US-11643408-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway REDX PHARMA PLC (GB) 2023-05-09 US disclosed
EP-3204378-B3 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY REDX PHARMA PLC (GB) 2022-05-25 EP disclosed
US-20210046076-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALING PATHWAY REDX PHARMA PLC (GB) 2021-02-18 US disclosed
US-10793560-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway REDX PHARMA PLC (GB) 2020-10-06 US disclosed
WO-2020040581-A1 NOVEL QUINOLINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT 고려대학교 산학협력단 2020-02-27 WO disclosed
US-20190330198-A1 COMPOUNDS AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2019-10-31 US disclosed
CN-107108565-B The N- pyridine yl acetamide derivatives of inhibitor as WNT signal transmission approach 莱德克斯制药公共有限公司 2019-08-23 CN disclosed
WO-2016055786-A1 N-PYRIDINYL ACETAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY REDX PHARMA PLC (GB) 2016-04-14 WO disclosed
CN-103772345-B A kind of preparation method of fluorinated ethylene carbonate SUZHOU FUTE BATTERY MATERIAL CO., LTD. (CN) 2016-01-20 CN disclosed
US-8124605-B2 Compositions and methods for modulating a kinase cascade KINEX PHARMACEUTICALS, LLC (US) 2012-02-28 US disclosed
US-20090149510-A1 Compositions and methods for modulating a kinase cascade OAKTREE FUND ADMINISTRATION, LLC 2009-06-11 US disclosed
CN-101022813-A Pyridine derivatives of indolin-2-ones, process for their preparation and their therapeutic use SANOFI AVENTIS (FR) 2007-08-22 CN disclosed
EP-1373323-B1 CO2-TERMINATED RUBBER FIRESTONE POLYMERS LLC (US) 2007-02-28 EP disclosed
EP-1373323-A1 CO2-TERMINATED RUBBER Firestone Polymers, LLC (US) 2004-01-02 EP disclosed
WO-2002079267-A1 CO2-TERMINATED RUBBER FIRESTONE POLYMERS, LLC (US) 2002-10-10 WO disclosed
US-6316577-B1 PHOTOSENSITIVITY AND DURABILITY; HODOGAYA CHEMICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-4373176-A ELECTROLYTE IS A TERTIARY AMINE OR DIPROPYLAMINE MONO SALT OF DODECANEDIOIC ACID SPRAGUE ELECTRIC COMPANY (US) 1983-02-08 US disclosed